Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02-14.
Jean-Bernard AuliacPascal DôSophie BayleHélène DoubreFlorent VinasJacques LetreutLionel FalcheroPierre Alexandre HaussPascal ThomasChristos ChouaidPublished in: Advances in therapy (2019)
The rarity of HER2-mutated NSCLCs requires specific studies.